about
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting GuidelinesIncreasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewType I interferons for induction of remission in ulcerative colitisBudesonide for induction of remission in Crohn's diseaseBudesonide for maintenance of remission in Crohn's diseaseBudesonide for maintenance of remission in Crohn's diseaseType I interferons for induction of remission in ulcerative colitisBudesonide for induction of remission in Crohn's diseaseTraditional corticosteroids for induction of remission in Crohn's diseaseReporting transparency: making the ethical mandate explicitQuality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomesThe REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statementThe reporting of studies using routinely collected health data was often insufficientCall to RECORD: the need for complete reporting of research using routinely collected health data.Setting the RECORD straight: developing a guideline for the REporting of studies Conducted using Observational Routinely collected DataValidation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada.Better research reporting to improve the utility of routine data for making better treatment decisions.Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative Data.Helping everyone do better: a call for validation studies of routinely recorded health data[The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement].Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. FoundationDevelopment and use of reporting guidelines for assessing the quality of validation studies of health administrative data.Validation of an algorithm to identify children with biopsy-proven celiac disease from within health administrative data: An assessment of health services utilization patterns in Ontario, Canada.Internet and electronic resources for inflammatory bowel disease: a primer for providers and patients.Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics.Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort studyThe use of relative incidence ratios in self-controlled case series studies: an overview.The RECORD reporting guidelines: meeting the methodological and ethical demands of transparency in research using routinely-collected health dataAltered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease.Inflammatory bowel disease: a Canadian burden of illness reviewSeasonal timing of the Royal College examination in general paediatrics: A survey of residents' preferencesCollagenous colitis and eosinophilic gastritis in a 4-year old girl: a case report and review of the literature.The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider PerspectivesThe common postgraduate year 1: A paediatric perspectiveAdrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis.Budesonide for Crohn's disease.Assessing the risk of intussusception and rotavirus vaccine safety in Canada.Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends.Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.
P50
Q21131774-1361BE0A-4A18-4CF3-91D5-D87E8C6B9C8BQ22250934-FD846235-6E31-4F29-B75B-1FE1A6438903Q24187202-F54CF344-00FF-40B1-8478-7CBF5830195EQ24187309-28B0FB63-50FE-4FE4-99A4-FFC33C80CE7CQ24194313-78B71651-03BC-47C6-9465-4183CD0BA36BQ24241252-A41F7DB3-1344-47D4-AE48-FE4947D38A8FQ24241993-410CB786-3A93-4457-B814-B0564F72C0E3Q24242729-361CE631-79B3-496D-8C2C-442429C06CD3Q24242955-A2EF66B6-A4DB-4FF9-AF40-62B7331350BDQ26765395-A4BF85FD-914E-4254-99A1-A27592C1E756Q26996289-2E18517A-FF52-43BB-BE34-14713A05AA3FQ28268166-DEBDA3BA-CF7D-4272-AC6E-5589835B4A39Q28587783-92B6A496-EBE1-4240-AB66-E9ED58465BFFQ30578669-69E20AD7-B680-432B-BE44-5F9D21340D3AQ30588907-15B1D9E7-A2DD-4712-999C-8F682E009FD2Q30810648-39DCAB8E-BA61-42F7-8DAC-D6CD06CFC2FBQ31050809-E40BB6B1-95EE-434A-9C17-0E1F4D1909A1Q31055892-33478F5C-72A4-41A4-B06C-5735D93EFB7CQ31083836-7305FF35-91C9-4C25-9A76-766EFC9F69FEQ31142047-B9882AB5-15BC-49CB-B324-5AE0D3C4DF1BQ33489952-7556C25E-DAD5-49F1-B7A0-B7794A4C7E53Q33737549-118A2495-3A0B-41B9-B3E8-FAA9460041ADQ33782933-1D579199-6A2C-47F2-AB9E-9538A9F5923DQ33853560-111E8C6F-1D13-4AAA-90CC-726BFB08C849Q34238868-E0CDAB51-11F0-4241-AD00-89FC7BCAB748Q34782481-DD5981FB-B494-43DE-908C-AC8A8E25A76EQ35300362-9BCACBCA-ACE8-412A-A1AF-72FE08EFA365Q36143663-B3179D4B-1145-4EE8-9CD2-BAE0A3ED9C75Q36178861-6927B9AB-9678-44B2-9AAC-85A652C2282CQ36201694-95711CDA-8224-4EEB-A651-FCB17D3BBA47Q36391797-039C35F2-2804-40B1-A0E0-08306BA40018Q36868930-018F246E-816D-439B-A86F-7EC5943CC3D2Q36918944-4060217F-3ACD-4E52-8F7A-0D2356D21881Q36997039-B363B783-8CCC-4754-AFDD-0DFDD499CFA3Q37298124-2EFACB87-43E2-4F65-9B5F-6D478D0E4C7AQ37326036-CDB01AAC-60A4-4192-B002-2645E7D61A0DQ37554383-B0C5061C-259B-4F57-A54E-9998BBFE4760Q37713784-FAA77FBC-B113-44CC-A9A2-453EFF88FF5DQ37766576-20AE3169-A848-4035-A85C-F9CD5E96214DQ37827687-2C15F86D-D831-4A9A-A07D-ECA226EDC2DB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eric I Benchimol
@ast
Eric I Benchimol
@en
Eric I Benchimol
@es
Eric I Benchimol
@nl
Eric I Benchimol
@sl
type
label
Eric I Benchimol
@ast
Eric I Benchimol
@en
Eric I Benchimol
@es
Eric I Benchimol
@nl
Eric I Benchimol
@sl
prefLabel
Eric I Benchimol
@ast
Eric I Benchimol
@en
Eric I Benchimol
@es
Eric I Benchimol
@nl
Eric I Benchimol
@sl
P106
P31
P496
0000-0001-8855-3598